Larimar Therapeutics, Inc. (LRMR) stock
LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.70−0.03 (-1.10%)
Close on Nov 12, 2026Market cap $280.48MP/E –Yield –
Larimar Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Larimar Therapeutics's enterprise value was $127.30M on Nov 11, 2026, against $127.59M a year earlier. Over the last 5 years it ranged from -$46.30M to $418.15M, with a median of $93.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $127.30M | -15.5% |
| 2025 | Dec 31, 2025 | $150.70M | +248.6% |
| 2024 | Dec 31, 2024 | $43.23M | -58.5% |
| 2023 | Dec 29, 2023 | $104.17M | +92.9% |
| 2022 | Dec 30, 2022 | $54.00M | -52.2% |
| 2021 | Dec 31, 2021 | $113.07M | -50.1% |
| 2020 | Dec 31, 2020 | $226.47M | -46.8% |
| 2019 | Dec 31, 2019 | $425.96M | -79.5% |
| 2018 | Dec 31, 2018 | $2.08B | +45.3% |
| 2017 | Dec 29, 2017 | $1.43B | +58.0% |
| 2016 | Dec 30, 2016 | $905.47M | -51.2% |
| 2015 | Dec 31, 2015 | $1.86B | -77.6% |
| 2014 | Dec 31, 2014 | $8.28B | – |
See a number that looks wrong?